2. Temporary Anti-Static Agents In contrast, temporary agents are usually applied as coatings or sprays. Their effectiveness can diminish over time or with exposure to environmental conditions like humidity. Examples include water-based or solvent-based solutions that contain cationic or anionic surfactants. While they offer immediate solutions for static control, their longevity and performance may be less stable compared to permanent additives.
Furthermore, the COVID-19 pandemic has underscored the importance of a resilient and reliable API supply chain. Disruptions caused by the pandemic revealed vulnerabilities within the global supply chain, prompting many pharmaceutical companies to rethink their sourcing strategies. In response, there is a growing trend towards reshoring or diversifying API production sites to mitigate risks and ensure a stable supply of critical ingredients.
Following the identification of a suitable API, the next step is the formulation development. This process involves combining the API with excipients to create a dosage form, such as tablets, capsules, or injectables. The formulation must ensure that the API is delivered effectively, maintaining its stability, solubility, and bioavailability. Pharmaceutical scientists work meticulously to optimize formulations that maximize therapeutic outcomes while minimizing side effects.
Chlorine is one of the most widely used chemicals in water purification. It is a powerful disinfectant that kills bacteria, viruses, and other pathogens present in water. Chlorination is often used in municipal water treatment plants and involves adding chlorine gas, sodium hypochlorite, or calcium hypochlorite to water. The process not only eliminates harmful microorganisms but also helps in the removal of unpleasant odors and tastes. However, the use of chlorine must be carefully monitored, as its reacts with organic matter can lead to the formation of byproducts such as trihalomethanes (THMs), which can pose health risks.